CN105169134A - Medicament for treating lymphadenectasis - Google Patents
Medicament for treating lymphadenectasis Download PDFInfo
- Publication number
- CN105169134A CN105169134A CN201510672524.XA CN201510672524A CN105169134A CN 105169134 A CN105169134 A CN 105169134A CN 201510672524 A CN201510672524 A CN 201510672524A CN 105169134 A CN105169134 A CN 105169134A
- Authority
- CN
- China
- Prior art keywords
- parts
- component
- fructus
- weight
- lymphadenectasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating lymphadenectasis. The medicament comprises a component A and a component B, wherein the component A is prepared from the following raw materials in part by weight: 8 to 15 parts of glabrous greenbrier rhizome, 5 to 8 parts of honeysuckle, 10 to 20 parts of fructus forsythia, 9 to 14 parts of stir-baked squama manitis, 6 to 12 parts of coptis chinensis, 4 to 10 parts of licorice root, 10 to 22 parts of seaweed and 9 to 18 parts of kelp; the component B is prepared from the following raw materials in part by weight: 14 to 35 parts of cocklebur fruit, 20 to 45 parts of puberulous glochidion herb, 22 to 42 parts of myrtle, 26 to 45 parts of abutilon indicum sweet and 200 to 300 parts of small intestine of pig. The medicament is administrated by combining two different components, is used for treating lymph node, and has the advantages of no toxic or side effect, good treatment effect and quick curative effect.
Description
[technical field]
The invention belongs to drug world, be specifically related to a kind of medicine for the treatment of lymphadenectasis.
[background technology]
Lymph node (Lymphnode) is the distinctive organ of mammal (aquatic bird also has two pairs of lymph nodes).Normal person's superficial lymph knot is very little, and diameter is many within 0.5 centimetre, smooth surface, softness, with surrounding tissue without adhesion, also without tenderness.When antibacterial enters body from injury, lymphocyte can produce lymphokine and antibody kill bacteria effectively.Result is lymph node endolymph biological cells and tissues cellular responsibility hypertrophy, makes lymphadenectasis, is called reactive hyperplasia of lymph node.What can cause reactive hyperplasia of lymph node also has virus, some chemicals, the toxic product of metabolism, the component of organization of degeneration and foreign body etc.Therefore, the lymph node of enlargement is the beacon tower of human body, it is an alarm device, if can not get timely treatment, local red and swollen heat pain will be caused, and normal with symptoms such as fear of cold heating, headaches, by anti-inflammation treatment timely, redness can disappear, but sometimes because inflammation causes hamartoplasia, can leave over a little scleroma.If inflammation fails to control in time, be diffused into lymph node and adhesion mutually, severe patient can form abscess.But nowadays and have the medicine for the treatment of lymphadenectasis etc.
[summary of the invention]
For the problems referred to above, the invention provides a kind of medicine for the treatment of lymphadenectasis, for treating because of lymphadenectasis, inflammation etc.
The present invention is achieved by the following technical solutions, and provide a kind of medicine for the treatment of lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 8 ~ 15 parts, Flos Lonicerae 5 ~ 8 parts, Fructus Forsythiae 10 ~ 20 parts, stir-baked SQUAMA MANITIS 9 ~ 14 parts, Rhizoma Coptidis 6 ~ 12 parts, 4 ~ 10 parts, Radix Glycyrrhizae, Sargassum 10 ~ 22 parts, Thallus Laminariae (Thallus Eckloniae) 9 ~ 18 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 14 ~ 35 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 20 ~ 45 parts, Fructus Rhodomyrti 22 ~ 42 parts, Herba abutili indici 26 ~ 45 parts, pig small intestine 200 ~ 300 parts.
Especially, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 10 parts, Flos Lonicerae 8 parts, Fructus Forsythiae 15 parts, stir-baked SQUAMA MANITIS 10 parts, Rhizoma Coptidis 8 parts, 6 parts, Radix Glycyrrhizae, Sargassum 15 parts, Thallus Laminariae (Thallus Eckloniae) 15 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 20 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 30 parts, Fructus Rhodomyrti 30 parts, Herba abutili indici 30 parts, pig small intestine 250 parts.
The manufacture method of instant component A is:
Rhizoma Smilacis Glabrae, Flos Lonicerae, Fructus Forsythiae, stir-baked SQUAMA MANITIS, Rhizoma Coptidis, Radix Glycyrrhizae, Sargassum, Thallus Laminariae (Thallus Eckloniae) are put into medicine kettle, adds 3 parts of water afterwards and boil, when the water in medicine kettle only remains a, filter and obtain medicinal liquid one; Add two parts of water afterwards to proceed to boil, when the water in medicine kettle only remains moiety, filter and obtain medicinal liquid two, medicinal liquid two and medicinal liquid one are merged, obtain component A medicinal liquid;
The manufacture method of instant component B is:
Fructus Xanthii, Fructus glochidionis puberi(Herba Glochidii Puberi), Fructus Rhodomyrti, Herba abutili indici are put into medicine kettle, adds 3 parts of water afterwards and boil, when the water in medicine kettle only remains a, filter and obtain medicinal liquid one; Add two parts of water afterwards to proceed to boil, when the water in medicine kettle only remains moiety, filter and obtain medicinal liquid two, medicinal liquid two and medicinal liquid one are merged, obtain B component medicinal liquid, by ripe for pig small intestine steaming and decocting.
Instructions of taking:
Component A medicinal liquid is divided into two parts by first day, takes night and morning; B component medicinal liquid and pig small intestine are divided into two parts respectively in second day, sooner or later respectively take portion; Intersection like this is taken, and after taking 10-20 days continuously, disease obtains medical treatment.
Compared to prior art, a kind of medicine for the treatment of lymphadenectasis provided by the invention, is combined by the medicine of two kinds of different components and takes, treat lymph node, this medicine have have no side effect, therapeutic effect is good, curative effect is fast advantage.
[detailed description of the invention]
In order to make object of the present invention, technical scheme and advantage clearly understand, below in conjunction with embodiment, the present invention is described in more detail.
Embodiment 1
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 10 parts, Flos Lonicerae 8 parts, Fructus Forsythiae 15 parts, stir-baked SQUAMA MANITIS 10 parts, Rhizoma Coptidis 8 parts, 6 parts, Radix Glycyrrhizae, Sargassum 15 parts, Thallus Laminariae (Thallus Eckloniae) 15 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 20 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 30 parts, Fructus Rhodomyrti 30 parts, Herba abutili indici 30 parts, pig small intestine 250 parts.
The manufacture method of instant component A is:
Rhizoma Smilacis Glabrae, Flos Lonicerae, Fructus Forsythiae, stir-baked SQUAMA MANITIS, Rhizoma Coptidis, Radix Glycyrrhizae, Sargassum, Thallus Laminariae (Thallus Eckloniae) are put into medicine kettle, adds 3 parts of water afterwards and boil, when the water in medicine kettle only remains a, filter and obtain medicinal liquid one; Add two parts of water afterwards to proceed to boil, when the water in medicine kettle only remains moiety, filter and obtain medicinal liquid two, medicinal liquid two and medicinal liquid one are merged, obtain component A medicinal liquid;
The manufacture method of instant component B is:
Mountain Rhizoma Solani tuber osi head, Fructus Xanthii, Fructus glochidionis puberi(Herba Glochidii Puberi), Fructus Rhodomyrti, Herba abutili indici are put into medicine kettle, adds 3 parts of water afterwards and boil, when the water in medicine kettle only remains a, filter and obtain medicinal liquid one; Add two parts of water afterwards to proceed to boil, when the water in medicine kettle only remains moiety, filter and obtain medicinal liquid two, medicinal liquid two and medicinal liquid one are merged, obtain B component medicinal liquid, by ripe for pig small intestine steaming and decocting.
Instructions of taking:
Component A medicinal liquid is divided into two parts by first day, takes night and morning; B component medicinal liquid and pig small intestine are divided into two parts respectively in second day, sooner or later respectively take portion; Intersection like this is taken, and after taking 10-40 days continuously, disease obtains medical treatment.
Embodiment 2
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 8 parts, Flos Lonicerae 12 parts, Fructus Forsythiae 10 parts, stir-baked SQUAMA MANITIS 14 parts, Rhizoma Coptidis 6 parts, 10 parts, Radix Glycyrrhizae, Sargassum 10 parts, Thallus Laminariae (Thallus Eckloniae) 18 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 35 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 20 parts, Fructus Rhodomyrti 42 parts, Herba abutili indici 26 parts, pig small intestine 300 parts.
Preparation method is identical with embodiment 1 with instructions of taking, repeats no more herein.
Embodiment 3
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 15 parts, Flos Lonicerae 6 parts, Fructus Forsythiae 20 parts, stir-baked SQUAMA MANITIS 9 parts, Rhizoma Coptidis 12 parts, 4 parts, Radix Glycyrrhizae, Sargassum 22 parts, Thallus Laminariae (Thallus Eckloniae) 9 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 14 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 45 parts, Fructus Rhodomyrti 22 parts, Herba abutili indici 45 parts, pig small intestine 200 parts.
Preparation method is identical with embodiment 1 with instructions of taking, repeats no more herein.
Embodiment 4
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 12 parts, Flos Lonicerae 9 parts, Fructus Forsythiae 13 parts, stir-baked SQUAMA MANITIS 11 parts, Rhizoma Coptidis 9 parts, 8 parts, Radix Glycyrrhizae, Sargassum 18 parts, Thallus Laminariae (Thallus Eckloniae) 12 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 24 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 25 parts, Fructus Rhodomyrti 26 parts, Herba abutili indici 34 parts, pig small intestine 220 parts.
Preparation method is identical with embodiment 1 with instructions of taking, repeats no more herein.
Embodiment 5
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 14 parts, Flos Lonicerae 10 parts, Fructus Forsythiae 18 parts, stir-baked SQUAMA MANITIS 12 parts, Rhizoma Coptidis 10 parts, 9 parts, Radix Glycyrrhizae, Sargassum 20 parts, Thallus Laminariae (Thallus Eckloniae) 13 parts;
The raw material of described B component calculates by weight, comprises following component: 25 ~ 40 parts, mountain Rhizoma Solani tuber osi head, Fructus Xanthii 20 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 40 parts, Fructus Rhodomyrti 35 parts, Herba abutili indici 40 parts, pig small intestine 280 parts.
Preparation method is identical with embodiment 1 with instructions of taking, repeats no more herein.
Should be understood that, in those skilled in the art, can be improved according to the above description or convert, and all these improve and convert the protection domain that all should belong to claims of the present invention.
Claims (2)
1. treat a medicine for lymphadenectasis, it is characterized in that, comprise component A and B component, the raw material of described component A is calculated by weight, composed of the following components:
Rhizoma Smilacis Glabrae 8 ~ 15 parts, Flos Lonicerae 5 ~ 8 parts, Fructus Forsythiae 10 ~ 20 parts, stir-baked SQUAMA MANITIS 9 ~ 14 parts, Rhizoma Coptidis 6 ~ 12 parts, 4 ~ 10 parts, Radix Glycyrrhizae, Sargassum 10 ~ 22 parts, Thallus Laminariae (Thallus Eckloniae) 9 ~ 18 parts;
The raw material of described B component calculates by weight, composed of the following components:
Fructus Xanthii 14 ~ 35 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 20 ~ 45 parts, Fructus Rhodomyrti 22 ~ 42 parts, Herba abutili indici 26 ~ 45 parts, pig small intestine 200 ~ 300 parts.
2. a kind of medicine for the treatment of lymphadenectasis according to claim 1, is characterized in that, comprise component A and B component, the raw material of described component A is calculated by weight, composed of the following components:
Rhizoma Smilacis Glabrae 10 parts, Flos Lonicerae 8 parts, Fructus Forsythiae 15 parts, stir-baked SQUAMA MANITIS 10 parts, Rhizoma Coptidis 8 parts, 6 parts, Radix Glycyrrhizae, Sargassum 15 parts, Thallus Laminariae (Thallus Eckloniae) 15 parts;
The raw material of described B component calculates by weight, composed of the following components:
Fructus Xanthii 20 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 30 parts, Fructus Rhodomyrti 30 parts, Herba abutili indici 30 parts, pig small intestine 250 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510672524.XA CN105169134A (en) | 2015-10-19 | 2015-10-19 | Medicament for treating lymphadenectasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510672524.XA CN105169134A (en) | 2015-10-19 | 2015-10-19 | Medicament for treating lymphadenectasis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105169134A true CN105169134A (en) | 2015-12-23 |
Family
ID=54891882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510672524.XA Pending CN105169134A (en) | 2015-10-19 | 2015-10-19 | Medicament for treating lymphadenectasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105169134A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007238559A (en) * | 2006-03-10 | 2007-09-20 | Nagoya City Univ | Immature dendritic cell-activating agent and use thereof |
CN101744963A (en) * | 2008-12-15 | 2010-06-23 | 张龙 | Traditional Chinese medicine preparation for detumescence by detoxification |
-
2015
- 2015-10-19 CN CN201510672524.XA patent/CN105169134A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007238559A (en) * | 2006-03-10 | 2007-09-20 | Nagoya City Univ | Immature dendritic cell-activating agent and use thereof |
CN101744963A (en) * | 2008-12-15 | 2010-06-23 | 张龙 | Traditional Chinese medicine preparation for detumescence by detoxification |
Non-Patent Citations (1)
Title |
---|
土荣华等: "《小偏方 大健康》", 31 August 2011 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102961729B (en) | Externally-used traditional Chinese medicine for treating varicosity, thromboangiitis obliterans and phlebitis | |
CN104547386A (en) | Hemorrhoids ointment | |
CN104740202A (en) | Medicine for treating skin itch | |
CN102100872A (en) | Chinese medicine preparation for treating mastitis | |
CN104547188A (en) | External preparation for treating varicosity and preparation method thereof | |
CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
CN101181475B (en) | Chinese medicine composition orally taken for curing acute eczema | |
CN104547599A (en) | Traditional Chinese medicine composition for treating kidney yang deficiency type chronic cervicitis and preparation method thereof | |
CN104758726A (en) | Traditional Chinese medicine composition for treating urinary tract infection | |
CN104107335A (en) | Traditional Chinese medicine composition for oral administration and external application for treating canker sore | |
CN104587312A (en) | Traditional Chinese medicine composition for treating constipation | |
CN104258236A (en) | Traditional Chinese medicine composition for nursing vaginas of women in puerperium | |
CN104069355A (en) | Medicinal composition for treating rheumatic arthritis and rheumatoid arthritis | |
CN105596769A (en) | Traditional Chinese medicine for treating scalds, bedsores and hemorrhoid | |
CN105169134A (en) | Medicament for treating lymphadenectasis | |
CN103127411B (en) | Traditional Chinese medicine used for treating urinary tract infection disease | |
CN101647957A (en) | Medicament for treating scald | |
CN104825617A (en) | Traditional Chinese medicine for treating rheumatism bone disease and traditional Chinese medicine bag | |
CN104606624A (en) | Traditional-Chinese-medicine composition for treating dampness and heat of liver and gallbladder | |
CN105878509A (en) | Preparation method of traditional Chinese medicine liquid for treating pruritic scrotal eczema | |
CN103845610A (en) | Medicament for treating prostatitis | |
CN103961656B (en) | A kind of Chinese medicine treating Chronic venous insufficiency | |
CN102940814B (en) | Medicine for treating tubal nowhere | |
CN105497727A (en) | Constipation treating traditional Chinese medicine composition | |
CN104474270A (en) | Traditional Chinese medicine composition and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151223 |
|
WD01 | Invention patent application deemed withdrawn after publication |